Charles Schwab’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.93M | Buy |
921,873
+156,620
| +20% | +$327K | ﹤0.01% | 2680 |
|
|
2025
Q1 | $1.3M | Sell |
765,253
-10,465
| -1% | -$17.8K | ﹤0.01% | 2755 |
|
|
2024
Q4 | $3.92M | Buy |
775,718
+54,400
| +8% | +$275K | ﹤0.01% | 2449 |
|
|
2024
Q3 | $3.92M | Buy |
721,318
+66,946
| +10% | +$364K | ﹤0.01% | 2486 |
|
|
2024
Q2 | $3.14M | Buy |
654,372
+180,605
| +38% | +$867K | ﹤0.01% | 2543 |
|
|
2024
Q1 | $1.47M | Sell |
473,767
-17,490
| -4% | -$54.4K | ﹤0.01% | 2678 |
|
|
2023
Q4 | $1.4M | Buy |
491,257
+32,794
| +7% | +$93.1K | ﹤0.01% | 2720 |
|
|
2023
Q3 | $1.34M | Buy |
458,463
+58,920
| +15% | +$173K | ﹤0.01% | 2703 |
|
|
2023
Q2 | $1.14M | Buy |
399,543
+3,190
| +0.8% | +$9.12K | ﹤0.01% | 2719 |
|
|
2023
Q1 | $1.22M | Sell |
396,353
-3,831
| -1% | -$11.8K | ﹤0.01% | 2673 |
|
|
2022
Q4 | $844K | Buy |
400,184
+96,460
| +32% | +$204K | ﹤0.01% | 2829 |
|
|
2022
Q3 | $991K | Sell |
303,724
-26,782
| -8% | -$87.4K | ﹤0.01% | 2800 |
|
|
2022
Q2 | $1.06M | Buy |
330,506
+28,864
| +10% | +$92.7K | ﹤0.01% | 2768 |
|
|
2022
Q1 | $2.13M | Buy |
301,642
+7,402
| +3% | +$52.3K | ﹤0.01% | 2623 |
|
|
2021
Q4 | $2.13M | Buy |
+294,240
| New | +$2.13M | ﹤0.01% | 2689 |
|